Idexx Laboratories (IDXX) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $57.6 million.
- Idexx Laboratories' Other Non-Current Liabilities fell 836.21% to $57.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.6 million, marking a year-over-year decrease of 836.21%. This contributed to the annual value of $44.3 million for FY2024, which is 3233.07% down from last year.
- As of Q3 2025, Idexx Laboratories' Other Non-Current Liabilities stood at $57.6 million, which was down 836.21% from $56.8 million recorded in Q2 2025.
- Idexx Laboratories' 5-year Other Non-Current Liabilities high stood at $85.0 million for Q2 2021, and its period low was $44.3 million during Q4 2024.
- Its 5-year average for Other Non-Current Liabilities is $65.4 million, with a median of $66.3 million in 2024.
- As far as peak fluctuations go, Idexx Laboratories' Other Non-Current Liabilities crashed by 3233.07% in 2024, and later soared by 635.25% in 2025.
- Over the past 5 years, Idexx Laboratories' Other Non-Current Liabilities (Quarter) stood at $70.9 million in 2021, then dropped by 4.73% to $67.6 million in 2022, then fell by 3.05% to $65.5 million in 2023, then tumbled by 32.33% to $44.3 million in 2024, then increased by 29.95% to $57.6 million in 2025.
- Its Other Non-Current Liabilities was $57.6 million in Q3 2025, compared to $56.8 million in Q2 2025 and $47.7 million in Q1 2025.